Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model-Reference-Cited by-同舟云学术

Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model

Published:2019-04 Issue: Volume:560 Page:136-143
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Rizvi Syed Zaki Husain,Shah Fawad Ali,Khan Namrah,Muhammad Iftikhar,Ali Khan Hashim,Ansari Muhammad Mohsin,Din Fakhar ud,Qureshi Omer Salman,Kim Kyoung-Won,Choe Yeong-Hwan,Kim Jin-Ki,Zeb Alam^ORCID

Funder

Higher Education Commission of Pakistan

National Research Foundation of Korea

Ministry of Science and ICT

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference55 articles.

1. Preparation, characterization, and anticancer effects of simvastatin–tocotrienol lipid nanoparticles;Ali;Int. J. Pharm.,2010

2. Design and production of nanoparticles formulated from nano-emulsion templates—A review;Anton;J. Controlled Release,2008

3. Rapid disintegrating tablets of simvastatin dispersions in polyoxyethylene-polypropylene block copolymer for maximized disintegration and dissolution;Balata;Drug Des. Dev. Ther.,2016

4. The single dose poloxamer 407 model of hyperlipidemia; systemic effects on lipids assessed using pharmacokinetic methods, and its effects on adipokines;Chaudhary;J. Pharm. Pharm. Sci.,2013

5. Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics;Choi;J. Pharm. Invest.,2018

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable dual thermoreversible hydrogel for sustained intramuscular drug delivery;Journal of Controlled Release;2024-10

2. Mucoadhesive aprepitant-loaded nanostructured lipid carriers containing sulfhydryl surfactant for enhanced oral drug bioavailability;Journal of Drug Delivery Science and Technology;2024-09

3. Selecting an Appropriate Animal Model for Dyslipidemia;Indian Journal of Pharmaceutical Education and Research;2024-08-10

4. Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment;Pharmaceuticals;2024-07-10

5. Optimization of variables and assessment of in-vitro and in-vivo antihyperlipidemic activity of Eudragit RS nanoparticles containing simvastatin;Particuology;2024-07